March 21, 2023
- A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes
- Challenges and Perspectives for Future Considerations in the Bioengineering of a Bioartificial Pancreas
- The relationship between FGF23 and body composition according to albuminuria stage in type 1 diabetes
- Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes
- Long-term cultures of human pancreatic islets in self-assembling peptides hydrogels (Full text HTML, PDF)
- Association of MicroRNA-146a with Type 1 and 2 Diabetes and their Related Complications (Full text HTML, PDF)
- Identification of hsa_circRNA_100632 as a novel molecular biomarker for fulminant type 1 diabetes
- Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant
- No Time to Die-How Islets Meet Their Demise in Transplantation
